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Comparisn ofpostneonatal mortality in social classesI and V over time
1970 Clasification of occupations 1980 Classification ofoccupations
Docennia
supplement DH3 series DH3 series
Social
class 1970-2 1975-6 1977-8 1979 1979 1980-1 1982-3
I 2-9 2-8 2-9 3-2 3-3 3-2 2-5
V 13-1 8-5 7-6 9 1 8-1 6-6 6-2
Ratio 4-5 3-0 2-6 2-8 2-5 2-1 2-5
Sources: Decennial supplement on occupatioal mortality, 1970-72. London: HMSO, 1978. OPCS Series SMPS No 41 and DH3
Nos 7, 9, 13-15. London: HMSO.
of classifying these social class data in 1979. The
table above extends the table presented by Pharoah
and Macfarlane to 1983 and includes OPCS 1979
bridge coded data. This suggests that over half the
fall in the ratio between 1975-6 and 1982-3 may be
ascribed to the change in classification.
Thus, although there has undoubtedly been a
real reduction in the class ratio over time, the
magnitude ofthe improvement is not as great as Dr
Gordon's figures imply. One possible reason for
the improvement that has taken place, suggested
by Pharoah and Macfarlane, could be that develop-
ments in neonatal care in the 1970s may have
delayed some deaths, causing them to be counted
in the postneonatal period. If this effect were
greatest in social groups or health areas with the
best medical care the paradoxical result would be a
narrowing of postneonatal gradients.
The lesson from all this is that, in focusing
attention on health indices based on only a narrow
part ofany set ofcontinuous data, there is always a
risk of -serious misinterpretations. This applies
equally to the measurement of class gradients and
of survival from birth.
PETER GOLDBLATr
Social Statistics Research Unit,
The City University,
London EC1V OHB
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SIR,-Although Dr R-R Gordon is correct in his
observation that according to published statistics
sociat class differences in postneonatal mortality
narrowed between 1970-2 and 1983, the news is
not-as good as his comments imply.
Firstly, as Peter Goldblatt points out, the data for
1970-2 were derived in a different way from those
from 1975 onwards and the way of classifying fathers'
occupations according to social class changed in 1979.
In addition, even when looking at the data for 1975
onwards, which apply to babies born within marriage,
it must be remembered that this group decreased from
90 90/o of all births in 1975 to 82-6% in 1984.'
The data shown in the figure have not been adjusted
to allow for these differences, but they illustrate the
most notable feature ofthe postneonatal mortality rate
for recent years-its failure to decline.2 3 Postneonatal
mortality does not seem to have declined since 1970-2
in babies of men in manual occupations. There has
also been very little decline since 1979 in death rates
among babies with fathers in non-manual occupa-
tions. In particular, death rates among babies with
fathers in unskilled occupations have fluctuated con-
siderably since 1979. Similar fluctuations can be seen
in the postneonatal death rates among babies born
outside marriage, which are not shown in the figure.
For England and Wales as a whole postneonatal
mortality rates remained almost constant from 1976 to
1982.3 Although there were small decreases in 1983
and 1984, there was no sign offurther decline in 1985.
A similar levelling off has been observed in many
other developed countries.45 Furthermore, there is a
narrowing of differences between countries similar to
that which, as Dr Gordon points out, has occurred
between English regions. He is, however, incorrect in
saying that about 900/o ofdeaths from 1 month to I year
are due to either congenital anomalies or the sudden
infant death syndrome. In 1984, 21% of these deaths
were due to congenital malformations and 41% to the
sudden infant death syndrome.6 Adding the further
6%, including a few attributed to congenital mal-
formations, where "sudden infant death" was men-
tioned elsewhere on the death certificate,7 means that
these two groups ofconditions accounted for just over
two thirds of postneonatal deaths.
The levelling off of postneonatal mortality rates
is difficult to interpret. It may reflect to some
extent the longer survival of babies receiving
neonatal intensive care, but other factors may play
a part.8 9
Meanwhile, although social class is a crude
measure, it does point to the existence of consider-
able differences in mortality between the most and
least favoured sectors of the population in mor-
tality, not only in the postneonatal period but also
in the perinatal period and throughout the first
year of life. Clearly the analyses in the Black report
need to be updated and extended, but this does not
invalidate its central message. Further research
should therefore be undertaken in the context of
commitment to action.
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National Perinatal Epidemiology Unit,
Radcliffe Infirmary,
Oxford OX2 6HE
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Angina pectoris-like pains provoked by
intravenous adenosine
SIR,-We read with interest the proposition ofDr
Christer Sylven and colleagues (26 July, p 227)
that adenosine may protect against myocardial
ischaemia by inducing the warning symptom of
angina. They base this hypothesis on data con-
firming that intravenous boluses of adenosine
can cause angina-like pain. We observe such
retrosternal pain associated with tightness in the
arms, neck, or epigastrium in only about half of
our subjects, perhaps because we titrate the dosage
individually: we did not so lightly disregard the
potential pathophysiological significance of the
symptoms as Dr Sylven and colleagues suggest.
We find, however, that similar sensations of
tightness in the arms, neck, or epigastrium are
induced when adenosine is infused into the aortic
arch.' Since the half life of adenosine is probably
less than 10 seconds,2 this might suggest that these
symptoms are not dependent on an intracoronary
effect and that the mechanism whereby adenosine
induces discomfort is more widespread. In particu-
lar, adenosine precisely reproduces the epigastric
pain of duodenal ulcer in patients with this con-
dition.3
Dr Sylven and colleagues assume that the
angina-like pain was not in fact due to myocardial
ischaemia. We agree. We studied the effects of
intravenous adenosine, given at cardiac catheteri-
sation with heart rate held constant during the
investigation of patients for chest pain subse-
quently shown not to be associated with any
cardiovascular abnormality; adenosine doubled
coronary flow without increasing inotropic state or
systolic tension.4
A caveat-we believe that the dose ofadenosine
should be titrated with care, particularly when
given in the presence of dipyridamole, as in the
case of one of our patients who developed severe
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bradycardia with 2'4 mg adenosine given for
supraventricular tachycardia.'
ANDREw H WATT
PETER G REID
PHILIP ROUTLEDGE
Department of Pharmacology and Therapeutics
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W J PENNY
A H HENDERSON
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University ofWales Coliege ofMedicine,
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SIR,-We were interested to read the report by
Dr Christer Sylven and colleagues (26 July, p 227)
of angina-like pain after bolus injections of adeno-
sine in normal subjects.
We have recently studied the symptoms and
cardiorespiratory effects of over 40 adenosine
infusions in nine normal subjects. With its plasma
half life of about 10 seconds' steady state plas-
ma concentrations of adenosine -can quickly be
achieved. Adenosine was infused for at least five
minutes in doses ranging from 40 to 120 Fg/kg/
min and caused dose related increases in pulse rate
and resting ventilation without changes in systemic
blood pressure.23 During these infusions symp-
toms of anxiety, chest and abdominal discomfort,
backache, jaw ache, and headache developed at
infusion rates above 80 pg/kg/min, and their
severity was thereafter dose related. These symp-
toms and the tachycardia were the factors that
limited the higher infusion rates. Characteristic of
the symptoms was their colicky nature, lasting for
30-45 seconds and occurring at intervals of 45 to
120 seconds. Other than tachycardia there were no
abnormalities on simultaneous electrocardio-
graphic records at any infusion rate.
Six of these subjects were given 60% oxygen or
air to breathe in a single blind manner during
adenosine infusion. Oxygen reduced both the
cardiorespiratory stimulation and the symptoms
caused by adenosine. In these six subjects the
effects of adenosine were compared before and
after intravenous theophylline or a saline place-
bo (given randomised and double blind; mean
plasma theophylline levels 9-5 (SD 0 9) mg/l).
Theophylline reduced both the cardiorespiratory
and symptomatic effects of adenosine when given
by infusion, as Dr Sylven and colleagues found
with injections of adenosine (although it is unfor-
tunate that they did not compare the effects of
theophylline with those of a placebo).
Adenosine infusion therefore establishes an
important characteristic of the symptoms caused
by this nucleoside which studies of bolus doses
could not reveal. The colicky nature of the symp-
toms, their reduction or disappearance with an
increase in-inspired P02, and their reduction or
absence after administration of theophylline raise
doubts about the hypothesis of Dr Sylven and
colleagues thatangina may bedue to the stimulation
of adenosine receptors. Angina is not classically
colicky, and theophylline is not noted for its relief
or prevention of angina. Although oxygen is used
in the management of angina, it is given primarily
to assist hypoxic myocardial tissue and is not
always effective in relieving angina.
The protean manifestations of angina pectoris
often make it a syndrome difficult to diagnose
without the knowledge of other characteristics of
the pain such as precipitating and relieving factors.
Adenosine has widespread effects in the body and
there are numerous receptors within the thorax
that may cause pain. In certain circumstances
adenosine may stimulate gastrointestinal smooth
muscle,4 and, as the authors implied, these symp-
toms of adenosine administration could equally be
those of gastrointestinal pain. We feel that their
recent hypothesis must remain in the realm of
speculation.
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Opiate withdrawal: inpatient versus
outpatient programmes
SIR,-I would like to make the following obser-
vation on the paper by Dr Michael Glossop and
colleagues (12 July, p 103).
The authors stated that "all (patients) were
physically dependent on opiates," and that the
mean dose of methadone "required for with-
drawal" was 37-5 mg/day. No further information
is given as to how physical dependence was deter-
mined or how the methadone requirement was
calculated. In practice it is often found that little
or no methadone is required to suppress any
abstinence syndrome. ' One possible reason for the
relative failure of the outpatient group might have
been that some patients significantly increased
their daily opiate intake over a prolonged period,
thus engendering, rather than reducing, their
dependence.
Secondly, the paper gives no indication of how
long a period of abstinence was confirmed by urine
analysis for the groups being compared. Fifty five
per cent of the outpatient group remained in
contact with the clinic,.compared with 29% of the
inpatient group. Ifone assumes that all those lost to
follow up are using drugs again (the gloomiest, but
most plausible, explanation) five weeks drug free
as an inpatient would appear to be antitherapeutic
for many patients.
Thirdly, urine analysis for drugs is notoriously
unreliable. No mention is made of the authors'
response to isolated positive findings in the absence
of other evidence of drug use.
Finally, it seems disingenuous of the authors to
compare their study with that of Edwards and
Guthrie, as their paper is methodologically far less
sophisticated. Edwards and Guthrie: (a) excluded
those of poor prognosis and those unwilling to be
randomly entered to their trial; (b) detoxified
inpatients and outpatients over the same time
period; (c) mobilised community resources to help
in treatment; (d) followed up their sample for 12
months.
Failure to establish "neurophysiological
dependence"; failure to randomise patients to
treatment groups, using different withdrawal
regimens for the two groups; and failure to provide
significant psychosocial support for the outpatient
group make it very hard to accept either the clinical
or the policy implications of the study.
ANDREw McBRIDE
Whitchurch Hospital,
CardiffCF4 7XB
1 Jenner FA, Gill PV. Helping heroin addicts to kick the habit.
BrMedJ 1985;291:344.
AUTHORS' REPLY-Many of Dr McBride's
criticisms appear to be due to a hasty reading ofour
paper since several are already answered in the
text. Some of his points, however, are due to his
misunderstanding the purpose of our study.
Firstly, determining the presence of physical
dependence and assessing the dose requirements
for withdrawal are fundamental problems for all
who are clinically involved with these issues. In the
absence of any definitive or agreed procedures,
repeated opiate positive urine results plus the
presence of clinical signs and self report data were
all of some use in these tasks. Further information
on methods of determining dependence- and
establishing methadone requirements at this clinic
are given elsewhere.' The existence of the opiate
withdrawal syndrome is well documented. It
would be unfortunate if Dr McBride's suggestion
was interpreted to mean that abrupt and un-
modified withdrawal was an appropriate method of
detoxifying opiate addicts. He suggests that the
outpatient groups may have. been using extra
drugs without our knowledge. This would have
been possible only if they had been using extra
methadone, since any other opiate or non-opiate
drug would have been detected by the urine
analysis that was conducted at each clinic attend-
ance. In any case additional drug use would have
increased the failure rate for the outpatient pro-
grammes and would have reinforced rather than
weakened our conclusions.
Secondly, Dr McBride appears to be confused
about the aims ofour study. This is clearly stated in
the first sentence of the Discussion. We were
comparing methods of getting opiate addicts off
drugs. We were not looking at ways of preventing
subsequent relapse. These two phases oftreatment
are known to be independent,2 and detoxification
alone is known to be ineffective as a means of
preventing relapse.3
Thirdly, on what basis does Dr McBride assert
that urine analysis for drugs is "notoriously un-
reliable"? The DHSS guidelines of good clinical
practice state that urine analysis is a necessary and
centrally important part of diagnosis.4 Our own
procedures, which require the passing of speci-
mens under supervision, and analysis based on
chromatographic methods backed up with the
more sensitive glucuronidase hydrolysis, have
always proved reliable. Perhaps Dr McBride could
suggest a better objective means of detecting the
use of drugs? Our results were not based solely on
urine analysis but used other clinical data to
suggest the use ofdrugs. Urine analysis was used as
a confirmatory measure.
Finally, (a) our study clearly included subjects
willing to be randomly allocated to the different
treatment options and our results showed this not
to have a significant effect (paragraph 2, Results);
(b) the different time periods for the inpatient
and outpatient programmes are discussed in
both paragraph 2 of the Methods section and
paragraph 4 of the Discussion; (c) our paper is
obviously not intended to challenge the findings of
Edwards and Guthrie.s We refer to that important
